Cyclic nucleotide phosphodiesterases specificity

GTP-bound a-subunit activates a cGMP-specific phosphodiesterase as described briefly earlier. A benzophenone derivative of cGMP was prepared and found to inhibit several types of cyclic nucleotide phosphodiesterases at low concentrations. In rod outer segment preparations, the [a-32P]-tagged probe... 

When the hormonal stimulus stops, the intracellular actions of cAMP are terminated by an elaborate series of enzymes. cAMP-stimulated phosphorylation of enzyme substrates is rapidly reversed by a diverse group of specific and nonspecific phosphatases. cAMP itself is degraded to 5 -AMP by several cyclic nucleotide phosphodiesterases (PDE Figure 2-13). Competitive inhibition of cAMP degradation is one way caffeine, theophylline, and other methylxanthines produce their effects (see Chapter 20). 

The regulatory role of calcium ions in intermediary metabolism is well documented. Calcium has been shown to be involved in activation or inhibition of specific enzyme systems [105], For example, it activates cyclic nucleotide phosphodiesterase, phosphofructokinase, fructose 1 6 biphosphatase, glycerol phosphate dehydrogenase, pyruvate dehydrogenase phosphatase and pyruvate dehydrogenase kinase. Calcium ions inhibit pyruvate kinase, pyruvate carboxylase, Na+/K+-AT-Pase and adenylate cyclase. 

Cyclic GMP, like AMP, can be inactivated by a specific cyclic nucleotide phosphodiesterase to 5 -GMP. Similarly, the biological effects of cGMP are believed to involve a cGMP-dependent protein kinase, also known as protein kinase G (PKG) or G-kinase. The cellular targets for G-kinase-mediated relaxation are unknown in ASM, and do not appear to involve phosphorylation of MLCK. However, in vascular smooth muscle cGMP and thus G-kinase may be involved in the extrusion of Ca " from the cytosol (Suematsu etal., 1984 Popescu etal., 1985) and in sr Ca sequestration (Twort and van Breemen, 1988), ultimately leading to relaxation. 

PKG and cyclic nucleotide phosphodiesterases (PDEs) (reviewed by Baxter37). A rapid release of natriuretic peptides and induction of their de novo synthesis occurs in myocardial ischemia. Natriuretic peptides may have a cardioprotective role. BNP-32 administration in perfused rat hearts prior to left main coronary artery occlusion and until 30 min of reperfusion resulted in limitation of infarct size in a concentration dependent manner. Furthermore, this effect was abolished by 5-hydroxydecanoate (presumed to be a selective blocker of mitochondrial KATp channels), L-NAME, an inhibitor of NOS and ODQ, a specific soluble guanyl cyclase inhibitor.38 Similarly, human recombinant ANP limited infarct size and reperfusion arrhythmias in a canine model of coronary occlusion and reperfusion.39... 

Lugnier C (2006) Cyclic nucleotide phosphodiesterase (PDE) superfamily a new target for the development of specific therapeutic agents. Pharmacol Ther 109 366-398... 

Cyclic AMP is catabolized to 5 -adenosine monophosphate by the enzyme cyclic nucleotide phosphodiesterase, which terminates any further cAMP-initiated reactions. This enzyme also requires Mg + for activity. Calcium, again in consort with calmodulin, can stimulate phosphodiesterase activity. Phosphodiesterase appears to exist in multiple forms, each with specificity toward different substrates. Calcium and calmodulin activate only one form of the enzyme. The enzyme is potently inhibited by methyl xanthines, such as caffeine, theophylline, and theobromine. It is believed that at least part of the pharmacological effects of such compounds can be explained through their inhibition of phosphodiesterase and the consequent reduction in the catabolism of cAMP. 

Two of the seven cyclic nucleotide phosphodiesterase gene families PDE3 and PDE4, have a high affinity of cAMP and are specifically inhibited by ci-lostamide and rolipram, respectively. Using these inhibitors in assays with 0.1 [ H]cAMP as substrate, Gao et al. (1996) found PDE3 activity... 

Purification of a cyclic nucleotide phosphodiesterase Affinity chromatography of carbohydrate-specific immunoglobulins Purification of chicken pepsin... 

KS-502 (43) was isolated in 1989 [26] and identified as a specific inhibitor of calmodulin-dependent cyclic-nucleotide phosphodiesterase (CaM-PDE). The important roles of CaM and CaM-PDE in cultured cells and living systems underscored the utility of KS-502, perhaps as a valuable biological tool. Its structure comprises an interesting aryl furanoside for which new methodology was devised. 

Cyclic nucleotides are made in response to receptor activation. The receptor activates a G-protein that, in turn, activates adenylyl cyclase to make the cyclic nucleotide. To complete the signaling, the increase in cAMP concentration activates a specific protein kinase (serine/threo-nine), cAMP-dependent protein kinase (A kinase) (Fig. 9-7). To turn off the signaling pathway, the cyclic nucleotides are destroyed by enzymes called phosphodiesterases. These cleave cAMP to AMP. 

---